Algert Global LLC Boosts Stock Position in Proto Labs, Inc. $PRLB

Algert Global LLC boosted its holdings in shares of Proto Labs, Inc. (NYSE:PRLB) by 137.3% during the 1st quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The fund owned 85,084 shares of the industrial products company’s stock after purchasing an additional 49,230 shares during the quarter. Algert Global LLC’s holdings in Proto Labs were worth $2,981,000 at the end of the most recent quarter.

Several other hedge funds and other institutional investors also recently bought and sold shares of the business. American Century Companies Inc. increased its holdings in Proto Labs by 38.8% during the 1st quarter. American Century Companies Inc. now owns 73,004 shares of the industrial products company’s stock worth $2,558,000 after purchasing an additional 20,425 shares during the last quarter. Russell Investments Group Ltd. increased its holdings in shares of Proto Labs by 91.8% in the 1st quarter. Russell Investments Group Ltd. now owns 38,679 shares of the industrial products company’s stock valued at $1,355,000 after acquiring an additional 18,508 shares during the last quarter. Public Sector Pension Investment Board increased its holdings in shares of Proto Labs by 27.2% in the 1st quarter. Public Sector Pension Investment Board now owns 77,679 shares of the industrial products company’s stock valued at $2,722,000 after acquiring an additional 16,598 shares during the last quarter. Nuveen LLC bought a new stake in shares of Proto Labs in the 1st quarter valued at approximately $2,458,000. Finally, Invesco Ltd. increased its holdings in shares of Proto Labs by 5.4% in the 1st quarter. Invesco Ltd. now owns 101,970 shares of the industrial products company’s stock valued at $3,573,000 after acquiring an additional 5,234 shares during the last quarter. 84.54% of the stock is currently owned by hedge funds and other institutional investors.

Proto Labs Price Performance

Shares of PRLB opened at $47.6880 on Thursday. The company has a market cap of $1.14 billion, a P/E ratio of 79.48 and a beta of 1.33. The stock has a fifty day moving average price of $41.61 and a 200 day moving average price of $39.19. Proto Labs, Inc. has a 12 month low of $26.34 and a 12 month high of $49.39.

Proto Labs (NYSE:PRLB) last issued its quarterly earnings data on Thursday, July 31st. The industrial products company reported $0.41 EPS for the quarter, topping analysts’ consensus estimates of $0.33 by $0.08. The firm had revenue of $135.06 million during the quarter, compared to the consensus estimate of $128.05 million. Proto Labs had a return on equity of 2.22% and a net margin of 2.91%.The firm’s revenue was up 7.6% on a year-over-year basis. During the same period in the prior year, the business earned $0.38 EPS. Proto Labs has set its Q3 2025 guidance at 0.350-0.430 EPS. As a group, research analysts anticipate that Proto Labs, Inc. will post 0.81 earnings per share for the current year.

Insider Buying and Selling

In related news, CEO Suresh Krishna acquired 1,725 shares of the stock in a transaction that occurred on Monday, August 4th. The stock was purchased at an average cost of $43.51 per share, for a total transaction of $75,054.75. Following the purchase, the chief executive officer directly owned 18,021 shares in the company, valued at $784,093.71. This represents a 10.59% increase in their ownership of the stock. The purchase was disclosed in a filing with the SEC, which is accessible through this link. 1.70% of the stock is currently owned by insiders.

Wall Street Analysts Forecast Growth

PRLB has been the subject of a number of research analyst reports. Craig Hallum upgraded Proto Labs from a “hold” rating to a “buy” rating and set a $54.00 price target for the company in a report on Friday, August 1st. Wall Street Zen upgraded Proto Labs from a “buy” rating to a “strong-buy” rating in a report on Saturday, August 2nd. Finally, Cantor Fitzgerald boosted their price target on Proto Labs from $50.00 to $51.00 and gave the company an “overweight” rating in a report on Friday, August 1st. Two research analysts have rated the stock with a Buy rating and one has issued a Hold rating to the company. According to data from MarketBeat, Proto Labs currently has a consensus rating of “Moderate Buy” and an average target price of $52.50.

Proto Labs Profile

Proto Labs, Inc, together with its subsidiaries, operates as a digital manufacturer of custom parts in the United States and Europe. The company offers injection molding; computer numerical control machining; three-dimensional printing; and sheet metal fabrication products. It serves developers and engineers, who use 3D computer-aided design software to design products across a range of end-markets.